Free Trial

Applied DNA Sciences (APDN) Competitors

Applied DNA Sciences logo
$4.07 -0.14 (-3.33%)
Closing price 08/14/2025 04:00 PM Eastern
Extended Trading
$3.98 -0.09 (-2.21%)
As of 06:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

APDN vs. ULY, FTFT, MSPR, SOPA, ZBAI, GMHS, PAVS, ONFO, PMAX, and LIFW

Should you be buying Applied DNA Sciences stock or one of its competitors? The main competitors of Applied DNA Sciences include Urgent.ly (ULY), Future FinTech Group (FTFT), MSP Recovery (MSPR), Society Pass (SOPA), ATIF (ZBAI), Gamehaus (GMHS), Paranovus Entertainment Technology (PAVS), Onfolio (ONFO), Powell Max (PMAX), and MSP Recovery (LIFW). These companies are all part of the "business services" industry.

Applied DNA Sciences vs. Its Competitors

Applied DNA Sciences (NASDAQ:APDN) and Urgent.ly (NASDAQ:ULY) are both small-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, media sentiment, institutional ownership, dividends, valuation and risk.

22.2% of Applied DNA Sciences shares are owned by institutional investors. Comparatively, 28.3% of Urgent.ly shares are owned by institutional investors. 0.0% of Applied DNA Sciences shares are owned by insiders. Comparatively, 11.4% of Urgent.ly shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Applied DNA Sciences has a beta of -0.02, indicating that its stock price is 102% less volatile than the S&P 500. Comparatively, Urgent.ly has a beta of -1.42, indicating that its stock price is 242% less volatile than the S&P 500.

Urgent.ly has a consensus target price of $11.50, indicating a potential upside of 122.87%. Given Urgent.ly's stronger consensus rating and higher probable upside, analysts clearly believe Urgent.ly is more favorable than Applied DNA Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Applied DNA Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Urgent.ly
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Urgent.ly has a net margin of -23.20% compared to Applied DNA Sciences' net margin of -194.14%. Urgent.ly's return on equity of 0.00% beat Applied DNA Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Applied DNA Sciences-194.14% -66.95% -50.34%
Urgent.ly -23.20%N/A -56.95%

In the previous week, Urgent.ly had 6 more articles in the media than Applied DNA Sciences. MarketBeat recorded 12 mentions for Urgent.ly and 6 mentions for Applied DNA Sciences. Applied DNA Sciences' average media sentiment score of 0.22 beat Urgent.ly's score of 0.16 indicating that Applied DNA Sciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Applied DNA Sciences
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Urgent.ly
1 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Applied DNA Sciences has higher earnings, but lower revenue than Urgent.ly. Urgent.ly is trading at a lower price-to-earnings ratio than Applied DNA Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied DNA Sciences$3.43M0.52-$6.99M-$537.48-0.01
Urgent.ly$142.90M0.05-$44.03M-$32.42-0.16

Summary

Urgent.ly beats Applied DNA Sciences on 10 of the 16 factors compared between the two stocks.

Get Applied DNA Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for APDN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APDN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

APDN vs. The Competition

MetricApplied DNA SciencesPROTECTION IndustryIndustrials SectorNASDAQ Exchange
Market Cap$1.83M$2.20B$7.71B$9.84B
Dividend YieldN/A1.76%4.55%4.07%
P/E Ratio-0.0119.8325.9025.74
Price / Sales0.523.8999.02115.79
Price / CashN/A72.1428.5959.48
Price / Book0.029.594.356.15
Net Income-$6.99M$110.39M$797.05M$265.06M
7 Day Performance-4.68%1.80%0.86%2.60%
1 Month Performance-18.27%0.90%2.01%2.83%
1 Year Performance-98.76%183.62%32.62%25.58%

Applied DNA Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APDN
Applied DNA Sciences
0.2269 of 5 stars
$4.07
-3.3%
N/A-98.8%$1.83M$3.43M-0.0170News Coverage
Earnings Report
Short Interest ↑
ULY
Urgent.ly
2.7619 of 5 stars
$5.04
-1.2%
$13.50
+167.9%
-54.8%$7.12M$142.90M-0.16753News Coverage
Earnings Report
Analyst Forecast
Short Interest ↓
FTFT
Future FinTech Group
0.8161 of 5 stars
$1.77
-6.3%
N/A-44.5%$6.52M$2.16M0.0070Upcoming Earnings
Short Interest ↓
MSPR
MSP Recovery
N/A$0.69
-7.7%
N/AN/A$6.15M$18.25M0.003Earnings Report
SOPA
Society Pass
2.8199 of 5 stars
$1.12
-1.8%
$15.00
+1,239.3%
+37.3%$6.11M$7.11M-0.392,021Earnings Report
Upcoming Earnings
ZBAI
ATIF
N/A$5.85
-3.8%
N/AN/A$5.85M$620K-0.8110Negative News
GMHS
Gamehaus
N/A$1.89
+46.7%
N/AN/A$5.84M$145.24M0.00N/AGap Down
High Trading Volume
PAVS
Paranovus Entertainment Technology
1.5329 of 5 stars
$0.71
-8.7%
N/A-26.0%$5.72M$70K0.00220Short Interest ↓
Gap Up
ONFO
Onfolio
1.0395 of 5 stars
$0.98
-8.4%
N/A+34.6%$5.49M$7.86M-2.188News Coverage
Earnings Report
Short Interest ↓
PMAX
Powell Max
N/A$0.35
-2.3%
N/AN/A$5.33M$4.69M0.00N/ANews Coverage
LIFW
MSP Recovery
N/A$0.75
+0.8%
N/A-90.0%$4.90M$10.73M-0.013Gap Up

Related Companies and Tools


This page (NASDAQ:APDN) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners